|
HIBADH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.224800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.194400E-04 |
| Normal-vs-Stage2 |
3.559600E-01 |
| Normal-vs-Stage3 |
1.617920E-03 |
| Normal-vs-Stage4 |
2.93669533135699E-11 |
| Stage1-vs-Stage2 |
8.321900E-03 |
| Stage1-vs-Stage3 |
5.670400E-01 |
| Stage1-vs-Stage4 |
1.55310999999658E-05 |
| Stage2-vs-Stage3 |
3.098300E-03 |
| Stage2-vs-Stage4 |
2.25309999999368E-05 |
| Stage3-vs-Stage4 |
1.316150E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.010600E-04 |
| Normal-vs-AfricanAmerican |
1.84413999999578E-05 |
| Normal-vs-Asian |
9.963200E-04 |
| Caucasian-vs-AfricanAmerican |
5.710200E-02 |
| Caucasian-vs-Asian |
2.569000E-01 |
| AfricanAmerican-vs-Asian |
6.639800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.08520000000756E-05 |
| Normal-vs-Female |
7.768200E-04 |
| Male-vs-Female |
2.193600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.391350E-04 |
| Normal-vs-Age(41-60Yrs) |
4.741400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.287720E-02 |
| Normal-vs-Age(81-100Yrs) |
3.579100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.130600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.972200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.062800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.682800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.783900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.882630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.822400E-03 |
| Classical-VS-Follicular |
1.1356000000351E-06 |
| Classical-VS-Other |
3.283000E-01 |
| Classical-VS-Normal |
1.58790000004405E-06 |
| Tall-VS-Follicular |
2.05219996551875E-09 |
| Tall-VS-Other |
1.624150E-01 |
| Tall-VS-Normal |
1.21669999630925E-08 |
| Follicular-VS-Other |
8.558000E-01 |
| Follicular-VS-Normal |
1.986580E-01 |
| Other-VS-Normal |
8.487200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.097820E-01 |
| Normal-vs-N1 |
1.74227299254426E-12 |
| N0-vs-N1 |
7.61200003029927E-09 |
|
|
